EBF3 and melanoma: In contrast to the downstream promoter regions that were investigated previously, we investigated a CpG rich region upstream of the transcription start site (i.e. different region from that previously investigated), which together with our complementary observations, suggests that EBF3 may have oncogenic tumor promoting properties associated with melanoma metastasis.